| Record ID | marc_loc_2016/BooksAll.2016.part36.utf8:117460969:1684 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part36.utf8:117460969:1684?format=raw |
LEADER: 01684cam a22003974a 4500
001 2009019338
003 DLC
005 20100529085108.0
008 090507s2009 enka b 001 0 eng
010 $a 2009019338
015 $aGBA951609$2bnb
016 7 $a101504356$2DNLM
016 7 $a015265607$2Uk
020 $a9780470060858 (cloth)
020 $a0470060859 (cloth)
035 $a(OCoLC)ocn321009115
040 $aDNLM/DLC$cDLC$dBTCTA$dBAKER$dNLM$dYDXCP$dBWKUK$dUKM$dDLC
042 $apcc
050 00 $aRM301.27$b.S25 2009
060 00 $a2009 J-911
060 10 $aQV 771$bS163b 2009
082 00 $a615/.1901$222
100 1 $aMussen, Filip.
245 10 $aBenefit-risk appraisal of medicines :$ba systematic approach to decision-making /$cFilip Mussen, Sam Salek, Stuart Walker.
260 $aChichester, UK ;$aHoboken, NJ :$bWiley-Blackwell,$c2009.
300 $ax, 294 p. :$bill. ;$c25 cm.
504 $aIncludes bibliographical references and index.
505 0 $aConcept and scope of benefit-risk evaluation of medicines -- Criteria for a benefit-risk model : a conceptual framework -- Review of the current benefit-risk assessment models -- Defining a systematic approach to decision making -- Development and application of a benefit-risk assessment model based on multi-criteria decision analysis -- A future framework for benefit-risk appraisal of medicines.
650 0 $aDrugs$xTesting.
650 0 $aPharmaceutical policy$xDecision making.
650 12 $aDrug Evaluation$xstandards.
650 22 $aDecision Support Techniques.
650 22 $aModels, Theoretical.
650 22 $aRisk Assessment.
700 1 $aSalek, Sam.
700 1 $aWalker, Stuart R.,$d1944-